In addition, mutations in LMNA and ZMPSTE24 in patients lead to metabolic dysfunction, including type 2 diabetes and hepatic steatosis (Galant et al., 2016; Shackleton et al., 2000). Here, LMNA is linked to Hepatic steatosis.